[Bismuth encephalopathy: a reappraisal of risk factors].
D000284:Administration, Oral; D001729:Bismuth / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism; D001927:Brain Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D007410:Intestinal Diseases / Q000503:physiopathology; D007700:Kinetics; D012306:Risk
D001729:Bismuth
Les encéphalopathies bismuthiques: réévaluation du risque.